David M. Knott Jr’s Catalyst Pharmaceutical CPRX Stock Holding History

David M. Knott Jr’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-120,000	Closed	-$2.97M	–	88
2026 Q1	$2.97M	Sell	120,000 -69,000	-37%	-$1.64M	1.77%	18
2025 Q4	$4.41M	Hold	189,000	–	–	2.04%	12
2025 Q3	$3.72M	Buy	189,000 +13,000	+7%	+$267K	1.5%	16
2025 Q2	$3.82M	Sell	176,000 -36,000	-17%	-$850K	1.73%	11
2025 Q1	$5.14M	Buy	212,000 +2,000	+1%	+$45K	2.43%	10
2024 Q4	$4.38M	Sell	210,000 -2,000	-0.9%	-$43K	1.58%	11
2024 Q3	$4.21M	Hold	212,000	–	–	1.48%	18
2024 Q2	$3.28M	Buy	212,000 +24,148	+13%	+$376K	1.31%	15
2024 Q1	$2.99M	Buy	187,852 +62,402	+50%	+$940K	1.06%	19
2023 Q4	$2.11M	Buy	+125,450	New	+$1.71M	0.81%	22

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

David M. Knott Jr's CPRX Position: Q2 2026 in Review

David M. Knott Jr sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 120,000 shares — an estimated $2.97M sold.

David M. Knott Jr first reported a position in CPRX in Q4 2023 and held it in 10 quarters. The position peaked at $5.14M in Q1 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

David M. Knott Jr reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
David M. Knott Jr sold 120,000 Catalyst Pharmaceutical shares in Q2 2026, an estimated $2.97M.
David M. Knott Jr first reported a position in Catalyst Pharmaceutical in Q4 2023 and held it in 10 quarters.
David M. Knott Jr's Catalyst Pharmaceutical position peaked at $5.14M in Q1 2025.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.